Hôpital Privé Claude Galien
Quincy-sous-Sénart, 91480, France
NCT Number: NCT05122845
To be able to evaluate the predictive value of glycosylated ferritin as a predictive marker of hepatic iron stock in dialysis patients, we need to validate these results with a cohort of healthy volunteers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Quincy-sous-Sénart, 91480, France
This biological collection will include a sample of 2 dry tubes and 2 EDTA tubes. A haematological assessment (CBC, platelets, reticulocytes, Chr (hemoglobin content of reticulocytes), TP-INR, AST, ALT, GGT), measurement of biological markers of iron metabolism (ferritin, serum iron, CRP, transferrin, soluble receptors transferrin, transferrin saturation coefficient) as well as a creatinine assay to validate the normality of renal function in healthy volunteers (GFR established from the MDRD formula), a complete ionogram and a phosphocalcic balance being given the interactions in the dialysis patient (but also in normal subjects) between iron metabolism and phosphocalcic metabolism (calcemia, phosphoremia, PTH, 25OHD3, 1,25OH2D3) will be performed.
We will also study the links between iron overload in dialysis patients and the modulation of the synthesis of parathyroid hormone (intact PTH), FGF23, alpha Klotho and sclerostin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood test (10 tubes of 5mL) :
2 dry tubes 2 tube EDTA
Time frame: one day
it is only a serum and plasma bank constitution
GCS Ramsay Santé pour l'Enseignement et la Recherche
Other
Acronym: SPSSCD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03418181
Dialysis, Female Urogenital Diseases
Stevenage, United Kingdom
View Trial DetailsNCT07662564
Dialysis, Neurologic Manifestations
Fatih, İ̇stanbul, Turkey (Türkiye)
View Trial DetailsNCT04466865
Behavior, Chronic Disease
Denver, Colorado, United States
View Trial DetailsNCT07479888
Dialysis
Rouen, France
View Trial Details